News

'I've Followed The Rules — But I'm Still Left In The Dark': Teen Abroad Loses Survivor Benefit After Turning 18, Still Fighting For Back Pay
Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. Back a bold new approach to cancer treatment ...